Arterys partners with Combinostics to offer the most comprehensive Neuro AI suite on the market with a wide range of applications in neuroradiology
SAN FRANCISCO, Nov. 26, 2021 (GLOBE NEWSWIRE) — Arterys, the world’s leading vendor-neutral AI platform, today announced its partnership with Combinostics to make their AI imaging solution, cNeuro®, available on the Arterys Platform. This collaboration enables Arterys to have the most comprehensive Neuro AI suite on the market, covering a wide range of applications in neuroradiology.
Arterys has initially fully integrated the cMRI™ algorithms of the cNeuro suite and they will be available in the coming weeks through the FDA-cleared and CE-marked MICA platform for the installed base. The platform’s cloud SaaS model allows the cMRI™ workflow-enhancing algorithms to be delivered immediately to existing Arterys customers.
Developed by Combinostics, its AI-powered imaging solutions provide unparalleled decision support to radiology professionals. cMRI™ is a fully automated solution that enables more accurate and consistent assessments of patients with neurological disorders such as dementia and multiple sclerosis. These AI-based tools will be available in the Arterys Neuro AI suite and will enable radiologists to provide data-driven decision support and improved diagnosis.
We’re excited to make Combinostics innovations available to clinicians around the world,” said John Axerio-Cilies, Arterys Co-Founder and CEO. “We’ve tuned the experience for seamless workflow integration — toward the end of efficient and quantitative assessment imaging analysis for brain MRI that provides deep, fast and reliable insights.”
“We are excited to partner with Arterys to deliver Combinostics’ cNeuro suite on their AI platform for medical imaging,” said Richard Hausmann, CEO of Combinostics. “This powerful collaboration will enable more hospitals and healthcare organizations to access our fully automated MRI brain quantification and support early detection, differential diagnosis and patient monitoring for neurological disorders such as dementia or multiple sclerosis in their workflow.”
Combinostics’ AI-powered cNeuro product suite helps clinicians make a difference in the lives of patients with neurological disorders. By quantifying brain images and integrating patient data from multiple sources with insights from past patients, the company’s unique software tools provide radiologists and clinicians with the support they need for confident, evidence-based diagnostic and management decisions. The company was founded in 2014 and is headquartered in Tampere, Finland. For more information, visit www.combinostics.com.
Arterys is the market leader and the world’s first internet platform for medical imaging. The goal is to transform healthcare by transforming radiology. The Arterys platform is 100% web-based, AI-powered and FDA-approved, unlocking simple clinical solutions. For more information about Arterys, visit www.arterys.com
Press contact: Mollie Schane via firstname.lastname@example.org
This content is published through the press release distribution service at Newswire.com.